Atrium Therapeutics Inc (RNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 143,699 | 125,106 | 139,262 | 320,448 | 410,013 |
| Marketable Securities | 261,849 | 273,112 | 257,809 | 85,095 | 3,016 |
| Other current assets | 8,916 | 6,033 | 7,729 | 5,598 | 8,929 |
| TOTAL | $414,464 | $404,251 | $404,800 | $411,141 | $421,958 |
| Non-Current Assets | |||||
| PPE Net | 8,776 | 8,506 | 7,076 | 6,538 | 5,197 |
| TOTAL | $8,776 | $8,506 | $7,076 | $6,538 | $5,197 |
| Total Assets | $430,539 | $420,801 | $421,135 | $427,580 | $425,917 |
| Liabilities | |||||
| Current Liabilities | |||||
| TOTAL | $42,666 | $33,687 | $30,920 | $29,658 | $22,418 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $53,557 | $46,450 | $45,427 | $46,150 | $31,040 |
| Shareholders' Equity | |||||
| Retained earnings | -308,073 | -264,474 | -218,784 | -184,549 | -146,011 |
| Other shareholders' equity | 685,055 | 638,825 | 594,492 | 565,979 | 540,888 |
| TOTAL | $376,982 | $374,351 | $375,708 | $381,430 | $394,877 |
| Total Liabilities And Equity | $430,539 | $420,801 | $421,135 | $427,580 | $425,917 |